{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ1",
        "Protein_Change": {
          "ref": "E",
          "alt": "D",
          "position": "64"
        },
        "variant_string_id": "DJ1 E64D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the DJ1 gene are described as a second cause of autosomal recessive EOPD (PARK7). The patient with c.192G>C (p.E64D) showed reduced dopamine uptake and structural changes in DJ1 function.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links DJ1 mutations to autosomal recessive EOPD and describes functional consequences (e.g., reduced DAT binding, altered protein localization)."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Crystallography, immunocytochemistry, and PET are used to assess protein structure, localization, and clinical phenotypes.",
          "judgment": "Yes",
          "reasoning": "These assays directly relate to the disease mechanism (protein structure/function and dopamine transport abnormalities)."
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "Wild-type DJ1 is compared to mutant DJ1 in HEK293/COS7 cells. The patient's family members (homozygous vs. heterozygous) are used as functional controls.",
          "judgment": "Yes",
          "reasoning": "Controls (wild-type, family heterozygous) and replicates (cell line experiments) are explicitly mentioned."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "The L166P mutation (previously described as pathogenic) is used as a control for functional analysis.",
          "judgment": "Yes",
          "reasoning": "A known pathogenic variant (L166P) is used as a control to validate functional assays."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper reports reduced dopamine uptake and altered protein localization but does not quantify OddsPath or provide statistical analyses for OddsPath calculation.",
          "judgment": "Yes",
          "reasoning": "No explicit OddsPath calculation or statistical tests are reported for this variant."
        }
      ],
      "strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "DJ1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "L166P is described as a previously identified pathogenic mutation in PARK7-associated EOPD.",
          "judgment": "Yes",
          "reasoning": "The mutation is explicitly linked to autosomal recessive EOPD and functional defects in DJ1."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Immunocytochemistry and structural analysis are used to assess protein localization and function.",
          "judgment": "Yes",
          "reasoning": "These assays are directly relevant to the disease mechanism (protein localization and function)."
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "Wild-type DJ1 is compared to mutant DJ1 in cell lines, and family members are used as functional controls.",
          "judgment": "Yes",
          "reasoning": "Controls (wild-type, family heterozygous) and replicates (cell line experiments) are explicitly mentioned."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "The E64D mutation is used as a control for functional analysis.",
          "judgment": "Yes",
          "reasoning": "A known pathogenic variant (E64D) is used as a control to validate functional assays."
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The paper reports altered protein localization but does not quantify OddsPath or provide statistical analyses for OddsPath calculation.",
          "judgment": "Yes",
          "reasoning": "No explicit OddsPath calculation or statistical tests are reported for this variant."
        }
      ],
      "strength": "PS3_supporting"
    }
  ]
}